|
07 Mar 2011 |
Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon DNA Vaccine for Cervical Dysplasia Caused by HPV
|
|
04 Mar 2011 |
BioSante's Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study
|
|
02 Mar 2011 |
Bayhill Therapeutics Announces the Successful Clearance of an IND for BHT-3034 for the Treatment of Myasthenia Gravis
|
|
02 Mar 2011 |
Baxter’s PREFLUCEL Seasonal Influenza Vaccine Receives European Repeat Mutual Recognition Approval
|
|
02 Mar 2011 |
Vical Receives Positive Scientific Advice From EMA for TransVax Phase 3 Trial
|
|
01 Mar 2011 |
VaxInnate Awarded Contract by the U.S. Government To Develop Recombinant Seasonal and Pandemic Flu Vaccines
|
|
01 Mar 2011 |
Novavax Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences for South Korea and Other Countries
|
|
28 Feb 2011 |
AFFIRIS ANNOUNCES AN EXTENSION OF ITS EXISTING ALZHEIMER´S DISEASE VACCINE DEVELOPMENT COLLABORATION WITH GLAXOSMITHKLINE TRIGGERING A EUR 3.5 MILLION PAYMENT TO AFFiRiS
|
|
23 Feb 2011 |
GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
|
|
23 Feb 2011 |
Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
|
|
22 Feb 2011 |
Dynavax Reports New Phase 1a and Phase 1b Data for Universal Flu Vaccine Candidate
|
|
22 Feb 2011 |
Dynavax Reports Additional Positive Phase 1B Immunogenicity Data for Hepatitis B Therapy Candidate
|
|
22 Feb 2011 |
Transgene Announces the Termination by Roche of the License Agreement on TG4001/RG3484 for the Treatment of Diseases Caused by the Human Papilloma Virus (''HPV'')
|
|
21 Feb 2011 |
Intercell announces start of pivotal Phase II/III study in India for vaccine to protect children from Japanese Encephalitis
|
|
18 Feb 2011 |
Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine
|
|
18 Feb 2011 |
NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
|
|
18 Feb 2011 |
Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
|
|
16 Feb 2011 |
New Pneumococcal Vaccine Approach Successful in Early Tests
|
|
14 Feb 2011 |
Diamyd Medical: Last Patient Completes the EU Phase III Study of Diamyd® Antigen Based Therapy for Type 1 Diabetes
|
|
09 Feb 2011 |
Liquidia Technologies Announces Collaboration with the Path Malaria Vaccine Initiative
|
|
08 Feb 2011 |
Medicago receives FDA regulatory clearance to initiate U.S. clinical trial for a new influenza vaccine candidate
|
|
07 Feb 2011 |
Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
|
|
03 Feb 2011 |
New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL in Males
|
|
02 Feb 2011 |
Inovio Pharmaceuticals' Dual-Antigen SynCon DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
|
|
02 Feb 2011 |
ImmunoCellular Therapeutics Announces First Patient Enrolled In Its Phase II Trial of ICT-107
|
